Royalty Pharma plc Business Finance Contracts & Agreements
25 Contracts & Agreements
- Credit Agreements (2 contracts)
- Exchange Agreements (3)
- Indenture Agreements (5)
- Purchase Agreements (5)
- Registration Rights Agreements (5)
- Share Agreements (2)
- Underwriting Agreements (3)
- Amended and Restated Revolving Credit Agreement, dated as of September 15, 2021, as amended by Amendment No. 1, dated as of October 31, 2022, as amended by Amendment No. 2, dated... (Filed With SEC on December 27, 2023)
- Second Supplemental Indenture, dated as of July 26, 2021, Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee (Filed With SEC on July 26, 2021)
- Underwriting Agreement, dated as of July 15, 2021 by and among Royalty Pharma plc, Royalty Pharma Holdings Limited, RP Management, LLC and the underwriters named therein (Filed With SEC on July 16, 2021)
- Amendment No. 2 to the Amended and Restated Purchase and Sale Agreement, dated October 30, 2020, by and among RPI Finance Trust, RPI 2019 Intermediate Finance Trust and Cystic... (Filed With SEC on November 5, 2020)
- Registration Rights Agreement, dated as of September 2, 2020, among Royalty Pharma plc, Royalty Pharma Holdings Ltd, BofA Securities, Inc., Citigroup Global Markets Inc., Goldman... (Filed With SEC on October 13, 2020)
- First Supplemental Indenture, dated as of September 2, 2020, among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee (Filed With SEC on October 13, 2020)
- Indenture, dated as of September 2, 2020, among Royalty Pharma plc, Royalty Pharma Holdings Ltd and Wilmington Trust, National Association, as Trustee (Filed With SEC on October 13, 2020)
- Amendment No. 1 to the Amended and Restated Purchase and Sale Agreement, dated October 13, 2016 with the Cystic Fibrosis Foundation (Filed With SEC on October 13, 2020)
- Amended and Restated Purchase and Sale Agreement, dated November 14, 2014, with the Cystic Fibrosis Foundation Therapeutics Incorporated (Filed With SEC on October 13, 2020)
- Registration Rights Agreement dated June 18, 2020, among the Company and the Persons listed on Schedule A and Schedule B thereto (Filed With SEC on October 13, 2020)
- Exchange Agreement dated June 16, 2020, among the Company, Royalty Pharma Holdings Ltd, RPI US Partners 2019, LP, RPI International Holdings 2019, LP, RPI International Partners... (Filed With SEC on October 13, 2020)
- Form of Class A Ordinary Share Certificate (Filed With SEC on October 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 13, 2020)
- Registration Rights Agreement, dated as of September 2, 2020, among Royalty Pharma plc, Royalty Pharma Holdings Ltd., BofA Securities, Inc., Citigroup Global Markets Inc., Goldman... (Filed With SEC on September 2, 2020)
- First Supplemental Indenture, dated as of September 2, 2020, among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee (Filed With SEC on September 2, 2020)
- Indenture, dated as of September 2, 2020, among Royalty Pharma plc, Royalty Pharma Holdings Ltd. and Wilmington Trust, National Association, as Trustee (Filed With SEC on September 2, 2020)
- Registration Rights Agreement dated June 18, 2020, among the Company and the Persons listed on Schedule A and Schedule B thereto (Filed With SEC on June 19, 2020)
- Exchange Agreement dated June 16, 2020, among the Company, Royalty Pharma Holdings Limited, RPI US Partners 2019, LP, RPI International Holdings 2019, LP, RPI International... (Filed With SEC on June 19, 2020)
- Form of Class A Ordinary Share Certificate (Filed With SEC on June 11, 2020)
- Form of Underwriting Agreement (Filed With SEC on June 8, 2020)
- Amendment No. 1 to the Amended and Restated Purchase and Sale Agreement, dated October 13, 2016 with the Cystic Fibrosis Foundation (Filed With SEC on June 2, 2020)
- Amended and Restated Purchase and Sale Agreement, dated November 14, 2014, with the Cystic Fibrosis Foundation Therapeutics Incorporated (Filed With SEC on June 2, 2020)
- Form of Registration Rights Agreement (Filed With SEC on June 2, 2020)
- Form of Exchange Agreement (Filed With SEC on June 2, 2020)
- Credit Agreement, dated February 11, 2020, between RPI 2019 Intermediate Finance Trust, as borrower, Bank of America, N.A., as administrative agent, and certain lender parties... (Filed With SEC on May 22, 2020)
